212 related articles for article (PubMed ID: 30576525)
1. Effects of zolpidem and zaleplon on cognitive performance after emergent morning awakenings at Tmax: a randomized placebo-controlled trial.
Dinges DF; Basner M; Ecker AJ; Baskin P; Johnston SL
Sleep; 2019 Mar; 42(3):. PubMed ID: 30576525
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of zaleplon, zolpidem, and triazolam on memory, learning, and psychomotor performance.
Troy SM; Lucki I; Unruh MA; Cevallos WH; Leister CA; Martin PT; Furlan PM; Mangano R
J Clin Psychopharmacol; 2000 Jun; 20(3):328-37. PubMed ID: 10831020
[TBL] [Abstract][Full Text] [Related]
3. Sleep and residual sedation after administration of zaleplon, zolpidem, and placebo during experimental middle-of-the-night awakening.
Zammit GK; Corser B; Doghramji K; Fry JM; James S; Krystal A; Mangano RM
J Clin Sleep Med; 2006 Oct; 2(4):417-23. PubMed ID: 17557470
[TBL] [Abstract][Full Text] [Related]
4. Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance.
Verster JC; Volkerts ER; Schreuder AH; Eijken EJ; van Heuckelum JH; Veldhuijzen DS; Verbaten MN; Paty I; Darwish M; Danjou P; Patat A
J Clin Psychopharmacol; 2002 Dec; 22(6):576-83. PubMed ID: 12454557
[TBL] [Abstract][Full Text] [Related]
5. Effects of zolpidem and zaleplon on sleep, respiratory patterns and performance at a simulated altitude of 4,000 m.
Beaumont M; Batéjat D; Coste O; Van Beers P; Colas A; Clère JM; Piérard C
Neuropsychobiology; 2004; 49(3):154-62. PubMed ID: 15034230
[TBL] [Abstract][Full Text] [Related]
6. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Elie R; Rüther E; Farr I; Emilien G; Salinas E
J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
[TBL] [Abstract][Full Text] [Related]
7. A comparison of the residual effects of zaleplon and zolpidem following administration 5 to 2 h before awakening.
Danjou P; Paty I; Fruncillo R; Worthington P; Unruh M; Cevallos W; Martin P
Br J Clin Pharmacol; 1999 Sep; 48(3):367-74. PubMed ID: 10510148
[TBL] [Abstract][Full Text] [Related]
8. Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.
Roth T; Hull SG; Lankford DA; Rosenberg R; Scharf MB;
Sleep; 2008 Sep; 31(9):1277-84. PubMed ID: 18788653
[TBL] [Abstract][Full Text] [Related]
9. Zaleplon and zolpidem objectively alleviate sleep disturbances in mountaineers at a 3,613 meter altitude.
Beaumont M; Batéjat D; Piérard C; Van Beers P; Philippe M; Léger D; Savourey G; Jouanin JC
Sleep; 2007 Nov; 30(11):1527-33. PubMed ID: 18041485
[TBL] [Abstract][Full Text] [Related]
10. Noise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplon.
Stone BM; Turner C; Mills SL; Paty I; Patat A; Darwish M; Danjou P
Br J Clin Pharmacol; 2002 Feb; 53(2):196-202. PubMed ID: 11851645
[TBL] [Abstract][Full Text] [Related]
11. Performance following a sudden awakening from daytime nap induced by zaleplon.
Whitmore JN; Fischer JR; Barton EC; Storm WF
Aviat Space Environ Med; 2004 Jan; 75(1):29-36. PubMed ID: 14736130
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.
Drover D; Lemmens H; Naidu S; Cevallos W; Darwish M; Stanski D
Clin Ther; 2000 Dec; 22(12):1443-61. PubMed ID: 11192136
[TBL] [Abstract][Full Text] [Related]
13. Cognitive performance following premature awakening from zolpidem or melatonin induced daytime sleep.
Storm WF; Eddy DR; Welch CB; Hickey PA; Fischer J; Cardenas R
Aviat Space Environ Med; 2007 Jan; 78(1):10-20. PubMed ID: 17225476
[TBL] [Abstract][Full Text] [Related]
14. The effect of zolpidem on cognitive function and postural control at high altitude.
Bouzat P; Séchaud G; Banco P; Davranche K; Casini L; Baillieul S; Manhes P; Botrè F; Mazzarino M; De la Torre X; Robach P; Verges S
Sleep; 2018 Oct; 41(10):. PubMed ID: 30099547
[TBL] [Abstract][Full Text] [Related]
15. Hypnotic efficacy of zaleplon for daytime sleep in rested individuals.
Whitmore JN; Fischer JR; Storm WF
Sleep; 2004 Aug; 27(5):895-8. PubMed ID: 15453547
[TBL] [Abstract][Full Text] [Related]
16. The effect of two benzodiazepine receptor agonist hypnotics on sleep-dependent memory consolidation.
Hall-Porter JM; Schweitzer PK; Eisenstein RD; Ahmed HA; Walsh JK
J Clin Sleep Med; 2014 Jan; 10(1):27-34. PubMed ID: 24426817
[TBL] [Abstract][Full Text] [Related]
17. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance.
Paul MA; Gray G; Kenny G; Pigeau RA
Aviat Space Environ Med; 2003 Dec; 74(12):1263-70. PubMed ID: 14692469
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of temazepam and zaleplon to induce afternoon sleep.
Simons R; Koerhuis CL; Valk PJ; Van den Oord MH
Mil Med; 2006 Oct; 171(10):998-1001. PubMed ID: 17076453
[TBL] [Abstract][Full Text] [Related]
19. Comparative kinetics and dynamics of zaleplon, zolpidem, and placebo.
Greenblatt DJ; Harmatz JS; von Moltke LL; Ehrenberg BL; Harrel L; Corbett K; Counihan M; Graf JA; Darwish M; Mertzanis P; Martin PT; Cevallos WH; Shader RI
Clin Pharmacol Ther; 1998 Nov; 64(5):553-61. PubMed ID: 9834048
[TBL] [Abstract][Full Text] [Related]
20. Effects of zolpidem/triazolam on cognitive performance 12 hours after acute administration.
Matsunaga Y; Tagaya H; Fukase Y; Hakamata Y; Murayama N; Kumagai Y; Kuroyama M
Sleep Med; 2018 Dec; 52():213-218. PubMed ID: 30097333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
